Article info
PDFPostScript
Letter
Risk of adverse events and reported clinical relapse after COVID-19 vaccination in patients with IBD
- Correspondence to Dr Rosanna Cannatelli, Gastroenterology and Digestive Endoscopy Unit, Department of Biochemical and Clinical Sciences "L. Sacco", University of Milan, ASST Fatebenefratelli Sacco, Milano, Lombardia, Italy; cannatelli.rosanna{at}asst-fbf-sacco.it
Citation
Risk of adverse events and reported clinical relapse after COVID-19 vaccination in patients with IBD
Publication history
- Received October 1, 2021
- Accepted November 16, 2021
- First published November 24, 2021.
Online issue publication
November 15, 2022
Article Versions
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage